title: Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin.
authors.forename: Anucha
authors.initials: A
authors.lastname: Apisarnthanarak
authors.forename: Linda M
authors.initials: LM
authors.lastname: Mundy
mesh_terms: D015780:Carbapenems / Q000008:administration & dosage / Q000494:pharmacology*; D003091:Colistin / Q000008:administration & dosage / Q000494:pharmacology*; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D000077726:Doripenem; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D005260:Female; D005578:Fosfomycin / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D053717:Pneumonia, Ventilator-Associated / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D015780:Carbapenems; D005578:Fosfomycin; D000077726:Doripenem; D003091:Colistin